KEQU — Kewaunee Scientific Balance Sheet
0.000.00%
- $159.32m
- $211.67m
- $240.47m
- 77
- 82
- 64
- 87
Annual balance sheet for Kewaunee Scientific, fiscal year end - April 30th, USD millions except per share, conversion factor applied.
2021 April 30th | 2022 April 30th | 2023 April 30th | 2024 April 30th | 2025 April 30th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 5.21 | 4.43 | 8.08 | 23.3 | 14.9 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 35 | 54.7 | 46.1 | 45.4 | 62.4 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 60.5 | 91.6 | 87.9 | 96.8 | 118 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 25.3 | 22.7 | 25.6 | 25.1 | 36.1 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 89.4 | 119 | 119 | 135 | 195 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 34.2 | 42.3 | 40.1 | 40.8 | 53.7 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 48.1 | 83.1 | 81.5 | 80 | 130 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 41.2 | 35.7 | 37.4 | 54.8 | 64.5 |
Total Liabilities & Shareholders' Equity | 89.4 | 119 | 119 | 135 | 195 |
Total Common Shares Outstanding |